| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | L M Ball | |
| EBMT Paediatric Working Party | |||
| R M Egeler | |||
| P2860 | cites work | Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy? | Q54719477 |
| Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age | Q59647415 | ||
| Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells | Q61053489 | ||
| Smarter rather than stronger treatment of haematological malignancies and non-malignant indications for stem-cell transplantation | Q64039160 | ||
| Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation | Q70184025 | ||
| Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation | Q70812614 | ||
| Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect | Q73785060 | ||
| Prevention of graft versus host disease by inactivation of host antigen-presenting cells | Q78016071 | ||
| Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantation | Q78494858 | ||
| Donor APCs are required for maximal GVHD but not for GVL | Q80402910 | ||
| Inflammatory cytokines and acute graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation | Q81159555 | ||
| Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination | Q82312167 | ||
| Expression of chemokines in GVHD target organs is influenced by conditioning and genetic factors and amplified by GVHR | Q83885898 | ||
| Prediction of graft-versus-host disease in humans by donor gene-expression profiling | Q21092376 | ||
| A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease | Q22251291 | ||
| Acute graft-vs-host disease: pathobiology and management | Q33940061 | ||
| Nonmyeloablative allogeneic stem cell transplantation: early promise and limitations | Q34100908 | ||
| Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis | Q34337007 | ||
| Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta | Q34517421 | ||
| The Pathophysiology of Acute Graft-versus-Host Disease | Q35578563 | ||
| Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management. | Q35889876 | ||
| Immunopathogenesis of acute graft-versus-host disease: implications for novel preventive and therapeutic strategies | Q35901997 | ||
| Non-HLA immunogenetics in hematopoietic stem cell transplantation | Q36221377 | ||
| New directions in the genomics of allogeneic hematopoietic stem cell transplantation | Q36714821 | ||
| An acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimens | Q40483853 | ||
| Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation | Q40516766 | ||
| CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes | Q40669542 | ||
| The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. | Q41061835 | ||
| Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected]. | Q41907086 | ||
| Marrow transplantation from related donors other than HLA-identical siblings | Q43519981 | ||
| Accumulation and activation-induced release of preformed Fas (CD95) ligand during the pathogenesis of experimental graft-versus-host disease | Q43710192 | ||
| The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation | Q44182914 | ||
| APCs in the liver and spleen recruit activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease | Q44241989 | ||
| Reduced intensity conditioning and prophylactic DLI can cure patients with high-risk acute leukaemias if complete donor chimerism can be achieved | Q44360452 | ||
| Minimal GVHD following in-vitro Tcell–depleted allogeneic stem cell transplantation with reduced-intensity conditioning allowing subsequent infusions of donor lymphocytes in patients with hematological malignancies and solid tumors | Q44612709 | ||
| Partial CD8+ T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graft-versus-host disease | Q45111052 | ||
| Donor methylenetetrahydrofolate reductase genotype is associated with graft-versus-host disease in hematopoietic stem cell transplant patients treated with methotrexate. | Q46976436 | ||
| Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease | Q47371499 | ||
| Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses. | Q47426162 | ||
| CD25 expression on donor CD4+ or CD8+ T cells is associated with an increased risk for graft-versus-host disease after HLA-identical stem cell transplantation in humans | Q47704184 | ||
| A possible role for CCL27/CTACK-CCR10 interaction in recruiting CD4 T cells to skin in human graft-versus-host disease. | Q53623998 | ||
| Critical role of interleukin-2 in the development of acute graft-versus-host disease. | Q53999839 | ||
| Methylenetetrahydrofolate reductase and thymidylate synthase genotypes and risk of acute graft-versus-host disease following hematopoietic cell transplantation for chronic myelogenous leukemia. | Q54586715 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pathogenesis | Q372016 |
| P304 | page(s) | S58-64 | |
| P577 | publication date | 2008-06-01 | |
| P1433 | published in | Bone Marrow Transplantation | Q4941523 |
| P1476 | title | Acute GvHD: pathogenesis and classification | |
| P478 | volume | 41 Suppl 2 |
| Q52922129 | A high migratory capacity of donor T-cells in response to the lymph node homing receptor CCR7 increases the incidence and severity of GvHD. |
| Q50540997 | Allogeneic Adipose-Derived Mesenchymal Stem Cell Transplantation Enhances the Expression of Angiogenic Factors in a Mouse Acute Hindlimb Ischemic Model. |
| Q44852729 | Allogeneic bone marrow grafts with high levels of CD4(+) CD25(+) FoxP3(+) T cells can lead to engraftment failure |
| Q35232833 | Anti-CMV-IgG positivity of donors is beneficial for alloHSCT recipients with respect to the better short-term immunological recovery and high level of CD4+CD25high lymphocytes |
| Q38827908 | Attenuation of graft-versus-host-disease in NOD scid IL-2Rγ(-/-) (NSG) mice by ex vivo modulation of human CD4(+) T cells. |
| Q90245997 | Baseline immune dysregulation in autologous stem cell transplant recipients is associated with a 'graft versus host'-like syndrome and poor outcomes |
| Q52651200 | Bat-mouse bone marrow chimera: a novel animal model for dissecting the uniqueness of the bat immune system. |
| Q34786954 | CD20, AIF-1, and TGF-beta in graft-versus-host disease: a study of mRNA expression in histologically matched skin biopsies |
| Q44550369 | Cellular immune function monitoring after allogeneic haematopoietic cell transplantation: evaluation of a new assay |
| Q52859900 | Dendritic polyglycerol sulfate attenuates murine graft-versus-host disease. |
| Q56890349 | Description of CD8 Regulatory T Lymphocytes and Their Specific Intervention in Graft-versus-Host and Infectious Diseases, Autoimmunity, and Cancer |
| Q51531971 | Effect of Splenectomy on Pancytopenia after a Peripheral Blood Stem Cell Transplantation |
| Q46121273 | Efficacy of dasatinib in a chronic myeloid leukemia patient with disease molecular relapse and chronic GVHD after haploidentical BMT: an immunomodulatory effect? |
| Q50605868 | Eosinophilia predicts better overall survival after acute graft-versus-host-disease. |
| Q45859255 | Evaluation of interleukin 12 and CD56+ lymphocyte cells in pediatric hematopoietic stem cell transplantation for early diagnosis of acute graft versus host disease |
| Q83225303 | Expression of CD64 (FcγRI) in skin of patients with acute GVHD |
| Q37015550 | Frequency and Outcome of Graft versus Host Disease after Stem Cell Transplantation: A Six-Year Experience from a Tertiary Care Center in Pakistan |
| Q44897853 | Gastrointestinal pathology of autologous graft-versus-host disease following hematopoietic stem cell transplantation: a clinicopathological study of 17 cases |
| Q33747297 | Genetic variations in the heparanase gene (HPSE) associate with increased risk of GVHD following allogeneic stem cell transplantation: effect of discrepancy between recipients and donors |
| Q48589365 | Hematopoietic Niche - Exploring Biomimetic Cues to Improve the Functionality of Hematopoietic Stem/Progenitor Cells |
| Q30234519 | Hematopoietic stem cell transplantation and acute kidney injury in children: A comprehensive review. |
| Q40622479 | Identification of Suitable Reference Genes for Normalization of Real-Time Quantitative Polymerase Chain Reaction in an Intestinal Graft-Versus-Host Disease Mouse Model |
| Q43471150 | Immunoproteomic analysis of potentially severe non-graft-versus-host disease hepatitis after allogenic bone marrow transplantation |
| Q35366857 | Indoleamine 2,3-dioxygenase in human hematopoietic stem cell transplantation. |
| Q47744316 | Inhibition of 5-lipoxygenase alleviates graft-versus-host disease. |
| Q58781733 | Joint Modeling of Immune Reconstitution Post Haploidentical Stem Cell Transplantation in Pediatric Patients With Acute Leukemia Comparing CD34-Selected to CD3/CD19-Depleted Grafts in a Retrospective Multicenter Study |
| Q45243246 | Lack of association of platelet-derived growth factor (PDGF) receptor autoantibodies and severity of chronic graft-versus-host disease (GvHD). |
| Q38694409 | Lactobacillus delivery of bioactive interleukin-22. |
| Q90590370 | Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marr |
| Q37566315 | Mesenchymal stem cells targeting the GVHD. |
| Q37812369 | Octreotide acetate is efficacious and safe in children for treating diarrhea due to chemotherapy but not acute graft versus host disease |
| Q90704538 | Optimal Donor Selection During Verification Process: Which Factors Are Worth Knowing? |
| Q49084600 | Outcome in critically ill patients with allogeneic BM or peripheral haematopoietic SCT: a single-centre experience |
| Q39252132 | Outcome of FLT3-ITD-positive acute myeloid leukemia: impact of allogeneic stem cell transplantation and tyrosine kinase inhibitor treatment. |
| Q39396157 | Photo-induced graft-versus-host disease. |
| Q40129363 | Potential for Monitoring Gut Microbiota for Diagnosing Infections and Graft-versus-Host Disease in Cancer and Stem Cell Transplant Patients. |
| Q48114774 | Pre-transplantation thymic function is associated with the risk of acute graft versus host disease and cytomegalovirus viremia after allogeneic hematopoietic stem cell transplantation. |
| Q28078893 | Preconditioning of Human Mesenchymal Stem Cells to Enhance Their Regulation of the Immune Response |
| Q37266089 | Psychosocial factors and hematopoietic stem cell transplantation: potential biobehavioral pathways |
| Q54186062 | Recipient and donor JAK2 46/1 haplotypes are associated with acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation. |
| Q84405865 | Relationship between TNFA, TNFB and TNFRII gene polymorphisms and outcome after unrelated hematopoietic cell transplantation in a Chinese population |
| Q38892351 | Remestemcel-L for the treatment of graft versus host disease. |
| Q37776504 | Solid Organ Transplant-Associated Acute Graft-Versus-Host Disease |
| Q47767583 | Surgical management of stem cell transplantation-related complications in children |
| Q38640486 | Targeting Cytokines in GVHD Therapy |
| Q37682117 | The Relationship between STR-PCR Chimerism Analysis and Chronic GvHD Following Hematopoietic Stem Cell Transplantation |
| Q54308886 | The Role of Anti-Thymocyte Globulin or Alemtuzumab-Based Serotherapy in the Prophylaxis and Management of Graft-Versus-Host Disease. |
| Q60938384 | The Role of Co-stimulatory/Co-inhibitory Signals in Graft-vs.-Host Disease |
| Q40852928 | The effect of extracorporeal photopheresis on T cell response in chronic graft-versus-host disease |
| Q40005125 | The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation. |
| Q38453666 | The potential of cytotherapeutics in hematologic reconstitution and in the treatment and prophylaxis of graft-versus-host disease. Chapter I: current practice and remaining unmet medical needs |
| Q38904894 | Transplacental maternal engraftment and posttransplantation graft-versus-host disease in children with severe combined immunodeficiency |
| Q37712454 | Treatment of Pediatric Acute Graft-versus-Host Disease-Lessons from Primary Immunodeficiency? |
| Q35901957 | Unrelated hematopoietic stem cell transplantation in the pediatric population: single institution experience |
Search more.